GLP-1 lunch content: what the food advice gets right and wrong
Quick answer
The creator is approximately six to seven weeks into tirzepatide therapy and reports significantly reduced appetite, eating sardines, eggs, a small chicken sandwich, and avocado as a grazing lunch with an emphasis on protein and hydration. Prioritizing protein during GLP-1 therapy is clinically supported, as appetite suppression can reduce total intake enough to accelerate lean mass loss alongside fat. Hydration reminders are also clinically relevant, since reduced food volume and GLP-1-related nausea can contribute to inadequate fluid intake.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @casharroyo actually say?
The short version: she's on tirzepatide, she's not hungry, and she's eating sardines, hard-boiled eggs, a small chicken sandwich, and avocado as a grazing lunch. Her core claim is that she prioritizes protein and water while on a GLP-1, and that sardines specifically deliver "22 grams of protein." She's not prescribing anything. She's just showing her plate.
It's worth being clear about what this video is and isn't. It's a food diary from someone six or seven weeks into tirzepatide. She calls herself a grazer, admits she's probably not the best food role model, and isn't telling anyone to eat what she eats. The protein-and-water emphasis is where the actual nutritional substance lives, and that's what's worth examining.
Does the science back this up?
On protein prioritization during GLP-1 therapy: yes, the evidence is real and it matters. The concern isn't just about eating less. GLP-1 receptor agonists reduce appetite significantly, and when people eat less, they risk losing lean muscle mass alongside fat. That's the problem protein helps prevent.
A 2023 study by Wilding et al. in the journal Diabetes, Obesity and Metabolism noted that weight loss from semaglutide included a meaningful proportion of lean mass, which raised clinical concern about preserving muscle during treatment. Separately, research on tirzepatide in the SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) showed substantial total body weight loss but did not isolate lean mass preservation as an outcome. The consensus from dietitians and obesity medicine specialists is that higher protein intake, roughly 1.2 to 1.6 grams per kilogram of body weight daily, is a reasonable target during GLP-1 therapy. Sardines and eggs are legitimately good sources. She's not wrong here.
What did they get wrong (or right)?
The sardine protein claim is close but slightly off. A standard 3.75-ounce can of sardines in water contains roughly 22 to 23 grams of protein depending on the brand, so that checks out as mostly accurate. No major issue there.
What she didn't address, and what matters clinically, is that grazing without structure can make it harder to hit adequate protein targets when your appetite is suppressed. If someone takes her video as permission to eat tiny scattered portions and call it good, they could under-eat significantly. The SURMOUNT-1 data showed some participants eating well under 1,200 calories, which is a threshold where micronutrient deficiencies become a real concern, not just a theoretical one.
She also mentions taking her tirzepatide the same day as the meal, which is fine, tirzepatide is a weekly injection and meal timing around it isn't a hard clinical rule. But she frames it loosely, and viewers should know that injection timing guidance should come from their prescriber, not a TikTok.
Credit where it's due: the water reminders are legitimate. GLP-1 users are at elevated risk for dehydration, partly because nausea can reduce fluid intake and because reduced food volume means less water from food sources.
What should you actually know?
If you're on a GLP-1 and taking food cues from social media, the protein priority is genuinely the right instinct. But "grazing" as a strategy needs guardrails. It's easy to feel full on very little and unknowingly drop below what your body needs to maintain muscle and basic nutrition.
A 2021 review by Koliaki et al. in Nutrients found that very low calorie intake without adequate protein accelerates muscle loss, which can reduce metabolic rate and make long-term weight maintenance harder. This is especially relevant for GLP-1 users because the appetite suppression can be dramatic enough that people don't register how little they're actually eating.
Sardines are a genuinely underrated food. They're high in protein, rich in omega-3 fatty acids, and contain vitamin D and calcium, particularly if you eat the bones. Eggs add complete protein and micronutrients. Avocado provides healthy fat and fiber. This is actually a reasonably balanced grazing plate, even if it arrived via vibes rather than a meal plan.
The bigger picture: no single creator's lunch is a protocol. What works for someone six weeks into tirzepatide may not translate to someone at a different dose, different starting weight, or with different metabolic needs. Use this as inspiration, not instruction.
Bottom line verdict
This video is mostly harmless and occasionally accurate. The protein emphasis is evidence-aligned. The specific foods are solid choices. The gaps are in what she doesn't say: that grazing without tracking can lead to under-eating on GLP-1s, and that anyone on tirzepatide should have actual clinical guidance, not just TikTok lunch tours, shaping their nutrition approach. She says it's not medical advice. She means it. Take her at her word.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For GLP-1 lunch content: what the food advice gets right and wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Tirzepatide Once Weekly for the Treatment of Obesity
Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability.
PubMed
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction
Used for continuation, stopping, and maintenance questions after initial weight loss.
PubMed
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.
PubMed
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus
Used for pages discussing stopping therapy, weight regain, and long-term planning.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
GLP-1 lunch content: what the food advice gets right and wrong is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
The creator is approximately six to seven weeks into tirzepatide therapy and reports significantly reduced appetite, eating sardines, eggs, a small chicken sandwich, and avocado as a grazing lunch with an emphasis on protein and hydration.
FormBlends verdict
The creator is approximately six to seven weeks into tirzepatide therapy and reports significantly reduced appetite, eating sardines, eggs, a small chicken sandwich, and avocado as a grazing lunch with an emphasis on protein and hydration. Prioritizing protein during GLP-1 therapy is clinically supported, as appetite suppression can reduce total intake enough to accelerate lean mass loss alongside fat. Hydration reminders are also clinically relevant, since reduced food volume and GLP-1-related nausea can contribute to inadequate fluid intake.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator is approximately six to seven weeks into tirzepatide therapy and reports significantly reduced appetite, eating sardines, eggs, a small chicken sandwich, and avocado as a grazing lunch with an emphasis on protein and hydration. Prioritizing protein during GLP-1 therapy is clinically supported, as appetite suppression can reduce total intake enough to accelerate lean mass loss alongside fat. Hydration reminders are also clinically relevant, since reduced food volume and GLP-1-related nausea can contribute to inadequate fluid intake.
- Tirzepatide (SURMOUNT-1, Jastreboff et al., 2022, NEJM) produced average weight loss of about 20 percent of body weight over 72 weeks, but lean mass loss is a documented concern that protein intake helps address.
- A 3.75-ounce can of sardines contains roughly 22 to 23 grams of protein, making them a genuinely efficient, high-protein food for people eating smaller volumes on GLP-1 therapy.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Tirzepatide (SURMOUNT-1, Jastreboff et al., 2022, NEJM) produced average weight loss of about 20 percent of body weight over 72 weeks, but lean mass loss is a documented concern that protein intake helps address.
- A 3.75-ounce can of sardines contains roughly 22 to 23 grams of protein, making them a genuinely efficient, high-protein food for people eating smaller volumes on GLP-1 therapy.
- Research consensus supports targeting approximately 1.2 to 1.6 grams of protein per kilogram of body weight daily during GLP-1-assisted weight loss to reduce muscle loss risk.
- Grazing without tracking total intake is a real risk on GLP-1s. Appetite suppression can be strong enough that users unknowingly eat below 1,000 to 1,200 calories daily, raising micronutrient deficiency concerns.
- Hydration is a legitimate clinical concern during GLP-1 therapy. Reduced food volume means less water from food sources, and nausea can further suppress fluid intake.
- This video is a personal food diary with a paid partnership disclosure, not a clinical nutrition protocol. Anyone on tirzepatide should get individualized guidance from their prescribing provider or a registered dietitian.
- Sardines also provide omega-3 fatty acids, vitamin D, and calcium (from bones), making them nutritionally dense beyond just protein, a fact the creator did not mention but that adds genuine value to her food choice.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Cash| PCOS SPECIALIST 💡 · TikTok creator
28.4K views on this video
🍽️ what I eat for lunch while on my GLP-1 💉 not medical advice, just my experience! everyone’s journey + needs are different. I get my prescription through @Mochi Health 💕 take the quiz in my bio to see if you’re a fit + use CASH40 for $40 off your first month ✨ #JoinMochiPartner #GLP1Journey #PCOS #HormoneHealth #CashArroyo
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Cash| PCOS SPECIALIST 💡, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.